Your browser doesn't support javascript.
loading
Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.
Ghelich Khan, Zahra; Talasaz, Azita Hajhossein; Pourhosseini, Hamidreza; Hosseini, Kianoush; Alemzadeh Ansari, Mohammad Javad; Jalali, Arash.
Afiliação
  • Ghelich Khan Z; Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Talasaz AH; School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. a-talasaz@tums.ac.ir.
  • Pourhosseini H; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. a-talasaz@tums.ac.ir.
  • Hosseini K; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Alemzadeh Ansari MJ; Shariati Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Jalali A; Rajaie Heart Center, Iran University of Medical Sciences, Tehran, Iran.
Clin Drug Investig ; 37(9): 853-860, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28608311
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alopurinol / Meios de Contraste / Intervenção Coronária Percutânea / Nefropatias Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alopurinol / Meios de Contraste / Intervenção Coronária Percutânea / Nefropatias Idioma: En Ano de publicação: 2017 Tipo de documento: Article